These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3834303)
21. [The significance of 2-thiol-propionamido-acetic acid in the treatment of cystic fibrosis]. Gargani GF; Vitiello B; Minicucci L; Micalizzi C; Richeri E; Romano C Minerva Pediatr; 1980 Nov; 32(22):1319-22. PubMed ID: 7219372 [No Abstract] [Full Text] [Related]
22. [Clinical and statistical study of the use of alpha-MPG in the treatment of viral hepatitis]. Bosio G; Marietti G Minerva Med; 1978 May; 69(22):1495-501. PubMed ID: 683551 [TBL] [Abstract][Full Text] [Related]
23. [Protective activity of tiopronin in relation to the acute exacerbation of chronic bronchitis]. Straneo G; Avanzini F; Scaglione F; Coppi G; Fraschini F Clin Ter; 1987 Mar; 120(6):503-10. PubMed ID: 2954743 [No Abstract] [Full Text] [Related]
24. [Histological and ultramicroscopic aspects of the small intestine in aregenerative enteropathies after treatment with 2-mercapto-propionyl-glycine (Thiola)]. Labò G; Gasbarrini G; Barbara L; Fontana G; Corazza GR Minerva Med; 1977 Jul; 68(36):2491-8. PubMed ID: 887228 [TBL] [Abstract][Full Text] [Related]
25. Pyrithioxine and thiopronine: new penicillamine-like drugs in rheumatoid arthritis. Camus JP; Crouzet J; Prier A; Bergevin H J Rheumatol Suppl; 1981; 7():175-7. PubMed ID: 6939882 [TBL] [Abstract][Full Text] [Related]
26. [New therapeutic prospects in lead poisoning: alpha-mercaptopropionylglycine]. Franco G; Malamani T; Scalisi L Minerva Med; 1979 Sep; 70(41):2811-9. PubMed ID: 492550 [TBL] [Abstract][Full Text] [Related]
27. [Study of changes in certain immunoglobulin fractions in acute and chronic hepatopathies treated with alpha-mercaptopropionylglycine]. Marinai E; Ulivieri P; Righi A Minerva Med; 1977 Dec; 68(62):4193-7. PubMed ID: 600464 [TBL] [Abstract][Full Text] [Related]
28. [Evaluation of the fraction of hepatocyte depuration before and after treatment with alpha-mercaptopropionylglycine in chronic hepatopathies]. Cortinovis A; Paolini FA; Crippa A Minerva Med; 1979 Dec; 70(54):3709-13. PubMed ID: 523002 [No Abstract] [Full Text] [Related]
30. Management of the patient with cystinuria. Pahira JJ Urol Clin North Am; 1987 May; 14(2):339-46. PubMed ID: 3576855 [TBL] [Abstract][Full Text] [Related]
31. [Cystinic lithiasis. Current therapeutic trends. Personal experience]. Tizzani A; Frea B; Linari F Minerva Urol; 1981; 33(4):253-8. PubMed ID: 7335035 [No Abstract] [Full Text] [Related]
32. 2-mercaptopropionylglycine in the treatment of the hyperviscosity syndrome. Triolo L; Magris D; Mian G Haematologica; 1980 Feb; 65(1):135. PubMed ID: 6768650 [No Abstract] [Full Text] [Related]
33. [Medical treatment of cystine lithiasis in children]. Laurenti C; De Dominicis C; Gallucci M; Iori F; Dal Forno S; Franco G J Urol (Paris); 1984; 90(2):117-21. PubMed ID: 6491345 [TBL] [Abstract][Full Text] [Related]
34. [Therapy of hepatic diseases with alpha-mercaptopropionylglycine]. De Pergola E; Carrozzini B; Selvaggio G; De Pergola G Minerva Med; 1982 May; 73(19):1297-9. PubMed ID: 7078808 [TBL] [Abstract][Full Text] [Related]
35. Clinical efficacy and adverse effects of tiopronin in rheumatoid arthritis. Report of a follow-up in 50 patients. Ambanelli U; Manganelli P; Ferraccioli GF Z Rheumatol; 1982; 41(5):235-9. PubMed ID: 7158085 [TBL] [Abstract][Full Text] [Related]
36. [Use of new mucolytic agent in bronchopulmonary pathology in children]. Spacagna G Minerva Pediatr; 1978 Aug; 30(15):1271-6. PubMed ID: 703706 [No Abstract] [Full Text] [Related]